Pricing Log in Create free account

Eledon Pharmaceuticals, Inc. (ELDN) vs InflaRx N.V. (IFRX)

Eledon Pharmaceuticals, Inc. and InflaRx N.V. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. is the larger, with a market value of $211.7M against $192.3M — 1.1× the size. Across the 10 metrics below, InflaRx N.V. leads on 6 and Eledon Pharmaceuticals, Inc. on 4.

Valuation

Metric ELDN IFRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6,308.89 9.40
P/B 8.98 1.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1,845.43 9.02
Earnings yield (34.87%) (29.70%) (32.88%)
Free cash flow yield (24.90%) (10.67%) (23.13%)

Profitability

Metric ELDN IFRX Biotechnology median
Gross margin 0.00% (26,762.42%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (236.51%) (30.98%) (51.96%)
Return on assets (72.74%) (25.90%) (46.06%)
Return on invested capital 0.00% (87.31%) 0.00%

Growth

Metric ELDN IFRX Biotechnology median
Revenue growth (TTM) — (83.39%) 6.76%
EPS growth (last fiscal year) 30.67% 9.41% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELDN IFRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.90 7.26 4.97
Net debt to EBITDA 1.60 0.97 1.01

Dividend

Metric ELDN IFRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELDN IFRX Biotechnology median
Market cap 211.69m 192.32m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack